Answer: Reported tolerability of these peptides is generally favorable in the literature, but they are not FDA-approved drugs, long-term human safety data is limited, and use should always be medically supervised
and in July 2024, the FDA approved Kisunla (donanemab) for early symptomatic Alzheimers, based on evidence of reduced clinical decline and a limitedduration regimen tied to amyloid plaque removal
This pattern aligns with how chronic metabolic conditions like diabetes are managedwith continuous medication rather than temporary intervention
For any individual biotech company, an investment thesis encompasses much more (e.g
Hydration: Maintaining good hydration is crucial when taking L-Carnitine, especially if you're using it around your workout sessions
For women with PCOS who may be trying to conceive, losing weight can make a difference for success